Joyo
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Joyo - overview
Established
2017
Location
Guangzhou, Guangdong, China
Primary Industry
Pharmaceuticals
About
Based in Guangzhou, China and established in 2017, Joyo is a pharmaceutical technology company that focuses on the research and development of tumor and autoimmune, metabolic and infectious disease drugs. The company has R&D center in Guangzhou, Shanghai, and Hangzhou. The company's R&D team has participated in First in Class (FIC), and Best in Class (BIC) drug R&D projects. In June 2023, the company closed a round of pre-series C funding.
The company engages in the research and development of tumor and autoimmune, metabolic and infectious disease drugs. The company developed PreClinical Candidate (PCC) drugs into Proof-of-Concept (PoC) drugs. It also has multiple innovative drug projects, including First in Class (FIC) and First in Disease (FID). The company will use the pre-series C funding to advance multiple mid- to late-stage clinical programs in the company's innovative drug pipeline, including clinical phase III for innovative drugs in infectious diseases and clinical phase II programs in multiple disease areas, including oncology and autoimmunity.
Current Investors
Yuexiu Industrial Investment Funds Management, Cisen Pharmaceutical Co., Ltd., Shanghai Lianhe Investment
Primary Industry
Pharmaceuticals
Sub Industries
Biotechnology, Oncology/Cancer Treatment, Pharmaceutical Research & Development
Company Stage
Series B
Total Amount Raised
Subscriber access only
Joyo - key contacts
| Name | Position | Start Date | End Date | Vcard | Bio | ||
|---|---|---|---|---|---|---|---|
| Board Member, Non Executive Director | BM |
BM Board Member
Want to see more?
Request a demo for full access to this profile
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.